Transwell assays revealed that the migration and invasion abilities of ACHN and 786-O cells increased after overexpression of WNT5A in PRMT2-knockdown RCC cells (Fig. 5E, F). The gene discussed is PRMT2; the disease is renal cell carcinoma.